Mesoblast (ASX:MSB) - Webinar Presentation

Company Presentations

by Finance News Network

Silviu Itescu - CEO - Mesoblast (ASX:MSB) is using its proprietary mesenchymal lineage cell technology platform to develop and commercialise innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?